Reported EPS |
$ | 4.73 | ||
Tax benefit (1) |
$ | (0.08 | ) | |
Litigation charge (2) |
$ | 0.11 | ||
Adjusted EPS |
$ | 4.76 | ||
| (1) | Represents the tax benefit relating to various tax settlements in multiple jurisdictions. | |
| (2) | Represents the charge relating to the pending settlement with the direct purchaser plaintiffs (which includes BD’s distributors) in the antitrust class actions. |
Reported EPS |
$ | 4.90 | ||
Tax charge (1) |
$ | 0.04 | ||
Adjusted EPS |
$ | 4.94 | ||
| (1) | Represents impact of non-cash charge related to health care reform impacting Medicare Part D reimbursements. |
| Total | ||||||||||||||||||||||||||||||||||||
| Q4 FY2010 | favorable | Foreign | Foreign | |||||||||||||||||||||||||||||||||
| Reported | Reported | Q4 | impact of | Q4 | foreign | currency | currency | |||||||||||||||||||||||||||||
| Q4 | Q4 | Change | FY2009 | foreign currency | FY2010 | currency | neutral | neutral growth | ||||||||||||||||||||||||||||
| FY2010 | FY2009 | ($) | hedge gain | translation | hedge gain | impact | growth ($) | (%) | ||||||||||||||||||||||||||||
EPS |
$ | 1.24 | $ | 1.20 | $ | 0.04 | ($0.03 | ) | $ | 0.02 | $ | 0.03 | 0.02 | $ | 0.02 | 1.7 | % | |||||||||||||||||||
| FY2009 | FY2010 | Total | Foreign | Foreign | ||||||||||||||||||||||||||||||||||||
| foreign | impact of | unfavorable | currency | currency | ||||||||||||||||||||||||||||||||||||
| currency | FY2009 | foreign | FY2010 | foreign | neutral | neutral | ||||||||||||||||||||||||||||||||||
| Change | holding | hedge | currency | hedge | currency | growth | growth | |||||||||||||||||||||||||||||||||
| FY2010 | FY2009 | ($) | gain | gain | translation | loss | impact | ($) | (%) | |||||||||||||||||||||||||||||||
Adjusted EPS |
$ | 4.94 | $ | 4.76 | $ | 0.18 | $ | (0.09 | ) | $ | (0.26 | ) | $ | 0.17 | $ | (0.08 | ) | $ | (0.26 | ) | $ | 0.44 | 9.2 | % | ||||||||||||||||